1. Goeptar AR, Te Koppele JM, Lamme EK, et al. Cytochrome P-450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. Mol Pharmacol. 1993;44:1267–1277.
2. Goeptar AR, Groot EJ, Scheerens H, et al. Cytotoxicity of mitomycin C and adriamycin in freshly isolated rat hepatocytes: the role of cytochrome P450. Cancer Res. 1994;54:2411–2418.
3. Minotti G . Adriamycin-dependent release of iron from microsomal membranes. Arch Biochem Biophys. 1989;268:398–403.
4. Van Acker SABE, Boven E, Kuiper K, et al. Monohyroxyethylrutoside, a dose dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin. Clin Cancer Res. 1997;3:1747–1754.
5. Van Acker FAA, Van Acker SABE, Kramer K, et al. MonoHER protects against chronic doxorubicin-induced cardiotoxicity when administered only once per week. Clin Cancer Res. 2000;6(4):1337–1341.